Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.11 | 0.7 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |